Topics
Glioblastoma | Treatment | Chemotherapy | Carmustine
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Carmustine
Roux A, Elia A, Aboubakr O,
Moiraghi A, Simboli GA, Tauziede-Espariat A, Dezamis E, Parraga E,
Benevello C, Fathallah H, Chretien F, Oppenheim C, Zanello M,
Pallud J.
Efficacy
and Safety of Carmustine Wafer Implantation After Ventricular
Opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in
Adults.
Neurosurgery.
2024 Jan 8. doi:
10.1227/neu.0000000000002817. PMID:
38189433. Observational study˰ ˍ
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S,
Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J,
Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H,
Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H,
Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T,
Endo H, Tominaga T.
Efficacy and
safety of carmustine wafers, followed by
radiation, temozolomide, and
bevacizumab therapy, for newly diagnosed
glioblastoma with maximal resection.
Int
J Clin Oncol. 2024 Nov 11. doi:
10.1007/s10147-024-02650-9. PMID:
39527165. Interventional study.
ˍ